Top Markets
Coin of the day
Mosaic ImmunoEngineering Inc. Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering Inc.

CPMV
Rangering i aksjer #38778
Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to... Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to the advancement and commercialization of an immunomodulatory platform technology. This innovative platform aims to provide therapeutic solutions for cancer and infectious diseases in both human and animal health. The company's core product is MIE-101, a nanoparticle-based treatment sourced from the cowpea mosaic virus, which has demonstrated non-infectious characteristics in mice, dogs, and humans. Headquartered in Novato, California, the company commenced operations in 2020.
Aksjekurs
$0.106
Sist synkronisert: 2026-10-01
Markedsverdi
$767.67K
Endring (1 dag)
73.77%
Endring (1 år)
-84.81%
Land
US
Handel Mosaic ImmunoEngineering Inc. (CPMV)

Kategori

EPS for Mosaic ImmunoEngineering Inc. (CPMV)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Mosaic ImmunoEngineering Inc. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Mosaic ImmunoEngineering Inc. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$17.32 -
US
$-7.98 -
US
$-5.29 -
AU
$27.74 -
NL
- -
CH